Ascites als Komplikation hepatischer Speicherung von Hydroxyethylstärke (HES) bei Langzeitdialyse
- 1 September 1984
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 62 (18) , 862-866
- https://doi.org/10.1007/bf01712005
Abstract
Three adult dialysis patients developed ascites after having received repeatedly the plasma substitue hydroxyethyl starch (HES 40/0.5). In two cases (total dose 180, and 330 g HES, respectively) the ascites was reversible after discontinuation of the HES administration. In the third case (total dose 915 g HES) the ascites could be controlled only by implantation of a Denver shunt. In this latter case it was shown by histological, electron microscopical, and biochemical findings that the ascites was caused by hepatic sinusoidal obstruction due to an extreme storage of HES in the sinusoidal lining cells. Additional storage was detected in hepatocytes, bile duct epithelia, endothelial cells, and fibroblasts in the portal tracts. Biochemically HES was found in liver tissue at a concentration of 4% (w/w). Although in renal impairment plasma clearance of HES is not significantly different from normal individuals, long-term administration of HES must be regarded inadvisable because of tissue storage which apparently is especially significant in this condition.This publication has 13 references indexed in Scilit:
- Iatrogenic multiorgan silicone inclusions in dialysis patientsJournal of Molecular Medicine, 1981
- [Determination of the plasma elimination of hydroxyethyl starch and dextran using improved analytical methods].1981
- Bestimmung der Plasmaelimination von Hydroxyaethylstärke und von Dextran mittels verbesserter analytischer MethodikTransfusion Medicine and Hemotherapy, 1981
- [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].1980
- ELIMINATION OF HIGH MOLECULAR-WEIGHT HYDROXYETHYLSTARCH IN RATS1980
- [Effect of kidney function on the elimination and action of colloidal plasma substitutes].1979
- [Hydroxyethyl starch (HAS 450/0.7) in human plasma and liver. Course of concentration and histological changes].1979
- [Mathematical decription of the human intravascular elimination of HAS after repeated infusions].1979
- [The effect of 6% hydroxyethyl starch 450/0.7, 10% dextran 40 and 3.5% gelatin on plasma volume in patients with terminal renal failure (author's transl)].1978
- [Reply to W. L. Thompson's commentary (Infusionstherapie 4:56-62 1977) on G. Lindblad's and J. Falk's study on "Course of hydroxyethyl starch and dextran concentration in blood and liver of rabbits and the histopathological consequences of hydroxyethyl starch storage (Infusionstherapie 3:301-3 1976)].1978